Literature DB >> 1552147

Pyridoxine-dependent seizures: report of a case with atypical clinical features and abnormal MRI scans.

R Tanaka1, M Okumura, J Arima, S Yamakura, T Momoi.   

Abstract

A Japanese girl with atypical pyridoxine-dependent seizures is reported. Until 9 months of age the seizures had been controlled by conventional anticonvulsants. The initial administration of pyridoxine was followed by a collapse; the suppression-burst pattern changed to an almost flat pattern in the EEG. T1- and T2-weighted magnetic resonance imaging (MRI) scans showed poor differentiation between white and gray matter, and T2-weighted MRI scans showed periventricular hyperintensity areas adjacent to the posterior horns of lateral ventricles. The findings in this patient indicate that pyridoxine should be given to infants with intractable epilepsy, regardless of the response to anticonvulsants, and that resuscitation facilities should be available during such a trial.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1552147     DOI: 10.1177/088307389200700104

Source DB:  PubMed          Journal:  J Child Neurol        ISSN: 0883-0738            Impact factor:   1.987


  4 in total

1.  Pyridoxine dependent epilepsy: a suggestive electroclinical pattern.

Authors:  R Nabbout; C Soufflet; P Plouin; O Dulac
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  1999-09       Impact factor: 5.747

Review 2.  Inherited disorders of GABA metabolism.

Authors:  C Jakobs; J Jaeken; K M Gibson
Journal:  J Inherit Metab Dis       Date:  1993       Impact factor: 4.982

3.  Antenatal treatment in two Dutch families with pyridoxine-dependent seizures.

Authors:  Levinus A Bok; Jasper V Been; Eduard A Struys; Cornelis Jakobs; Elisabeth A M Rijper; Michèl A Willemsen
Journal:  Eur J Pediatr       Date:  2009-07-09       Impact factor: 3.183

Review 4.  Pediatric neurotransmitter diseases.

Authors:  Phillip L Pearl; Denise D Wallis; K Michael Gibson
Journal:  Curr Neurol Neurosci Rep       Date:  2004-03       Impact factor: 5.081

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.